Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...
https://www.thehindubusinessline.com/companies/generic-versions-of-novo-nordisks-semaglutide-begin-to-flow-priced-50-80-lower-than-the-innovator/article70769849.ece ...
Hetero has launched its generic semaglutide portfolio in overseas markets even as it is awaiting regulatory approvals in India. The launch represents the beginning of a strategic, multi-year global ...
The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40% of the world’s population, significantly lowering the price of a costly medicine that ...
At Dr. David Macklin's weight management practice in Toronto, the name Ozempic is mentioned almost daily in appointments. But recently, another word is coming up just as often — generics. "It is a ...
AI Quick Read MUMBAI: A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddy’s, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the ...
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...
Pharmaceutical companies have launched generic versions of Ozempic in India, beating Canadians to market despite the drugs being legal in Canada for nearly three months. Novo Nordisk’s remaining ...
New Delhi [India], April 5 (ANI): US President Donald Trump has announced a sweeping 100 per cent tariff on select pharmaceutical imports, a move that comes shortly after a Jefferies report flagged ...
Sun Pharmaceutical, Dr. Reddy’s Laboratories, Zydus Life Sciences, and Glenmark Pharmaceuticals rolled out generic versions of Semaglutide on March 21, following the expiration of the patent on the ...
Multiple domestic pharmaceutical companies launched generic semaglutide on Saturday, a day after the drug's patent expired in India, with prices falling by as much as 90% from the branded version, ...
Alkem’s semaglutide pen devices will be marketed under the brand names Semasize, Obesema, and Hepaglide. Alkem Laboratories is positioning itself to lead India’s fast-growing weight-loss drug market, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results